Prevention of Diet-Induced Metabolic Dysregulation, Inflammation, and Atherosclerosis in LDLR −/− Mice by Treatment With the ATP-Citrate Lyase Inhibitor Bempec AcidHighlights
Arteriosclerosis, Thrombosis, and Vascular Biology - United States
doi 10.1161/atvbaha.116.308963
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2017
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)